Related Experiment Video
Updated: Jun 3, 2025

09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
KL-50: A novel therapeutic agent targeting MGMT-deficient glioblastoma
Kenan Zhang1, Mehdi Touat2, Mustafa Khasraw1
1Duke University Medical Center, Duke University, Durham, North Carolina, USA.
Neuro-Oncology
|January 8, 2025
Abstract
No abstract available in PubMed .

